D, N., A, Y., & A, R. (2021, October). Azacitidine Treatment in Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia According to their Cytogenetic Findings. Acta Medica Bulgarica.
Chicagoスタイル(17版)引用形式D, Nikolova, Yordanov A, , Radinov A. "Azacitidine Treatment in Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia According to Their Cytogenetic Findings." Acta Medica Bulgarica Oct. 2021.
MLA(9版)引用形式D, Nikolova, et al. "Azacitidine Treatment in Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia According to Their Cytogenetic Findings." Acta Medica Bulgarica, Oct. 2021.
警告: この引用は必ずしも正確ではありません.